Status:
UNKNOWN
High Flow Nasal Cannula Oxygen During Sedation for Video-assisted Thoracoscopic Surgery
Lead Sponsor:
Alexandria University
Conditions:
Chronic Obstructive Pulmonary Disease
Respiratory Failure
Eligibility:
All Genders
30-70 years
Phase:
PHASE2
Brief Summary
High-flow nasal cannula (HFNC) is a device that delivers10 to 70 L min-1 of heated, humidified 100% oxygen via nasal route. It provides positive airway pressure, decreases dyspnea, decreases the work ...
Detailed Description
Beneficial effects of the HFNC system have been assessed based on 3 physiologic conditions: decreased dead space, a high concentration of inspiratory oxygen, and positive pressure in the oro-laryngeal...
Eligibility Criteria
Inclusion
- ASA physical status II and III,
- undergoing VATS
Exclusion
- refusal of patients
- extrem of age
Key Trial Info
Start Date :
August 1 2020
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2020
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT04520568
Start Date
August 1 2020
End Date
December 1 2020
Last Update
August 20 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Rehab Abd Elraof Abd Elaziz
Alexandria, Egypt, 000000